Pancreaticoduodenectomy Procedure and Outcomes

Procedure Overview

The Whipple procedure involves removing the head of the pancreas, the duodenum, a portion of the stomach, the common bile duct, the gallbladder, and regional lymph nodes, followed by reconstruction to restore gastrointestinal and biliary continuity, as recommended by the American College of Surgeons 1, 2
The procedure requires complete mobilization of the portal and superior mesenteric veins from the uncinate process, and removal of the head of the pancreas, duodenum, distal stomach, common bile duct, gallbladder, and regional lymph nodes 2

Medial dissection requires complete mobilization of portal and superior mesenteric veins from the uncinate process, with a strength of evidence level of high 2
Skeletonization of the lateral, posterior, and anterior borders of the superior mesenteric artery maximizes uncinate yield and radial margin clearance, with a strength of evidence level of moderate 2
Vein resection and reconstruction may be necessary when tumor infiltrates the portal or superior mesenteric vein, with a strength of evidence level of low 2

After resection, three anastomoses are created to restore continuity, including pancreaticojejunostomy, hepaticojejunostomy, and gastrojejunostomy or duodenojejunostomy, with a strength of evidence level of high 1, 3, 4
Pylorus-preserving pancreaticoduodenectomy is the preferred approach for most pancreatic head tumors, offering comparable survival with superior nutritional outcomes and quality of life, with a strength of evidence level of moderate 1, 3, 4
Resectional surgery should be confined to specialist centers to reduce morbidity and mortality, with a strength of evidence level of high 3, 4

Pancreatic fistula is the most common major complication, occurring in approximately 3-12% of cases, with a strength of evidence level of low 5
Delayed gastric emptying occurs in 10-33% of patients and may require nasojejunal feeding, with a strength of evidence level of low 5
Five-year survival for pancreatic adenocarcinoma following resection is approximately 10%, with a strength of evidence level of moderate 1, 3, 4
All patients with resected pancreatic adenocarcinoma require adjuvant therapy due to high recurrence rates, with a strength of evidence level of high 1

The American Gastroenterological Association recommends pancreaticoduodenectomy (Whipple procedure) as the definitive surgical treatment for resectable malignancies of the pancreatic head and periampullary region, including pancreatic adenocarcinoma, ampullary carcinoma, distal bile duct cancer, and duodenal malignancies 6, 7
Preoperative evidence of venous encasement is a contraindication to resection, as it increases operative hazard without improving survival 6, 7, 8
Tumor involvement of the duodenal pylorus is rarely justified for Whipple procedure 6, 7

The American College of Surgeons recommends against routine preoperative biliary drainage in jaundiced patients, as it does not improve surgical outcome and may increase the risk of infective complications 6, 7, 9
Endoscopic plastic stents are preferred over self-expanding metal stents for preoperative biliary drainage, if necessary 10

Extended resections involving portal vein or total pancreatectomy may be required in select cases, but do not increase survival when carried out routinely 6, 7, 8
Pylorus-preserving pancreaticoduodenectomy is the preferred approach for most pancreatic head tumors, offering comparable survival with superior nutritional outcomes and quality of life 7, 9, 10

Resectional surgery should be confined to specialist centers to increase resection rates and reduce hospital morbidity and mortality 6, 7
Operative mortality is less than 5% at high-volume centers 6, 8

Five-year survival for pancreatic adenocarcinoma following resection is approximately 10-20% 7
All patients with resected pancreatic adenocarcinoma require adjuvant therapy due to high recurrence rates, with both gemcitabine-based and 5-FU-based chemotherapy regimens showing benefit 7